Press Releases

Mithra Submits Myring™ for European Marketing Approval
17 July 2017
EN FR

Mithra Strengthens E4 Patent Position in Australian Market
6 July 2017
EN FR

Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and Asean
28 June 2017
EN FR

Information on the total number of voting rights (denominator)
27 June 2017
EN FR

Estelle® Phase IIB Results on Well-Being and Body Weight Published in Leading Peer-Reviewed journal
26 June 2017
EN FR

Mithra Successfully Raises €26.1 Million
21 June 2017
EN FR

Mithra Launches a Capital Increase by Means of a Private Placement via an Accelerated Bookbuild Offering
21 June 2017
EN FR

Mithra Completes Recruitment for Additional Estelle® Safety Study
21 June 2017
EN FR

Mithra Receives Orphan Drug Designation from EMA for E4 in Neonatal Encephalopathy
9 June 2017
EN FR

Mithra Signs Exclusive Agreement for Tibelia® in Canada
6 June 2017
EN FR

Mithra Obtains Marketing Authorization for Tibelia® in France
29 May 2017
EN FR

Mithra Receives GMP Approval for Myring™ Production
23 May 2017
EN FR